thanks norberto, the sales price will definitly jump to over $10...

thanks norberto, the sales price will definitly jump to over $10 with a successful diabetees application. just as a snapshot, half the people in my office alone have it, so imagine the revenue it would bring in from the massive american market.

but that is the BIG unknown... with msb, picture in your mind someone sick going to a specialist and the specialist saying 'i have this treatment available developed by mesoblast' its still a long way from that stage hence making it high risk at even its current price $7.48. as i keep saying bad external factors are the reason for the current fall. If they had an announcement saying that they had a viable product ready to go the sales price would still be going up. TEVA and CEPH have not been affected by the sudden downturn on the u.s. markets as healthcare sector is solid. people will always get sick, but people can stop spending money as they are now leading to stock falls in the retail sector for example....